- Home
- VHC vs VRCA Comparison
VHC vs VRCA Comparison
Compare VHC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- VRCA
- Stock Information
- Founded
- VHC 2005
- VRCA 2013
- Country
- VHC United States
- VRCA United States
- Employees
- VHC N/A
- VRCA N/A
- Industry
- VHC Multi-Sector Companies
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- VHC Miscellaneous
- VRCA Health Care
- Exchange
- VHC Nasdaq
- VRCA Nasdaq
- Market Cap
- VHC 54.3M
- VRCA 58.7M
- IPO Year
- VHC 1999
- VRCA 2018
- Fundamental
- Price
- VHC $18.88
- VRCA $5.06
- Analyst Decision
- VHC
- VRCA Hold
- Analyst Count
- VHC 0
- VRCA 5
- Target Price
- VHC N/A
- VRCA $60.00
- AVG Volume (30 Days)
- VHC 9.6K
- VRCA 48.8K
- Earning Date
- VHC 08-12-2025
- VRCA 11-03-2025
- Dividend Yield
- VHC N/A
- VRCA N/A
- EPS Growth
- VHC N/A
- VRCA N/A
- EPS
- VHC N/A
- VRCA N/A
- Revenue
- VHC $50,000.00
- VRCA $14,704,000.00
- Revenue This Year
- VHC N/A
- VRCA $264.34
- Revenue Next Year
- VHC N/A
- VRCA $33.95
- P/E Ratio
- VHC N/A
- VRCA N/A
- Revenue Growth
- VHC 733.33
- VRCA 5.72
- 52 Week Low
- VHC $3.68
- VRCA $3.82
- 52 Week High
- VHC $21.53
- VRCA $20.90
- Technical
- Relative Strength Index (RSI)
- VHC 65.48
- VRCA 35.28
- Support Level
- VHC $14.30
- VRCA $4.91
- Resistance Level
- VHC $20.11
- VRCA $5.39
- Average True Range (ATR)
- VHC 1.32
- VRCA 0.39
- MACD
- VHC 0.66
- VRCA -0.05
- Stochastic Oscillator
- VHC 83.84
- VRCA 9.44
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.